drugset / Trial / NCT01604044

Highly Purified Menotropin (HP-hMG) Versus Recombinant FSH (rFSH) Plus Recombinant LH (rLH) in Intrauterine Insemination Cycles in Women ≥35 Years: a Prospective Randomized Trial.

NCT01604044

Phase 1 Completed 579 enrolled Catholic University of the Sacred Heart
RandomizedParallel-groupOpen-labelTreatment

Summary

This study evaluates the effects of different therapies in ovulation induction in Intrauterine Insemination Cycles.

Timeline

Start
2012-05
Primary completion
2013-09
Completion
2013-09

Drugs

EvaluationDrugModalityDoseRoute
Comparator Gonal-f Protein / enzyme biologic 150 iu Subcutaneous
Comparator Luveris Protein / enzyme biologic 150 iu Subcutaneous
Comparator Meropur Unknown 150 iu Subcutaneous

Indications